SCHEMBL21770523

SCHEMBL21770523

CNCCC(Oc1ccc(N(C)CCN(C)c2nc(SC)ncc2C=O)cc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 5/20 0.48
▸ CACNA2D1 P54289 4/20 0.48
▸ SLC6A4 P31645 12/20 0.45
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ LMNA P02545 4/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ MTOR P42345 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ HTR2C P28335 2/20 0.42
▸ SLC6A3 Q01959 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21770957 0.91 CACNA2D1 (0.50) SLC6A2CACNA2D1SLC6A4
SCHEMBL21770349 0.86 SLC6A2 (0.50) SLC6A2CACNA2D1SLC6A4MEN1KMT2A
SCHEMBL21770324 0.83 CACNA2D1 (0.51) SLC6A2CACNA2D1
SCHEMBL21770707 0.78 CACNA2D1 (0.52) SLC6A2CACNA2D1
SCHEMBL21770556 0.77 CACNA2D1 (0.51) SLC6A2CACNA2D1SLC6A4
SCHEMBL21770576 0.73 SLC6A2 (0.34) SLC6A2CACNA2D1MEN1KMT2ALMNA
SCHEMBL21770578 0.72 CACNA2D1 (0.41) SLC6A2CACNA2D1
SCHEMBL21770905 0.71 CACNA2D1 (0.52) SLC6A2CACNA2D1
SCHEMBL21770587 0.70 NOS1 (0.34) SLC6A2CACNA2D1
SCHEMBL9499069 0.68 SLC6A4 (0.75) SLC6A2SLC6A4MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452475-B1 TETRAHYDROPYRIMIDODIAZEPINE AND TETRAHYDROPYRIDODIAZEPINE COMPOUNDS FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS SA (ES) 2020-02-26 — — EP disclosed
Send feedback